These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4711518)

  • 41. Vasodilating effect of diphenylalkanolamines in anesthetized dogs.
    Kato H; Nishio S; Kasuya Y; Takagi K
    Chem Pharm Bull (Tokyo); 1973 Dec; 21(12):2689-94. PubMed ID: 4783167
    [No Abstract]   [Full Text] [Related]  

  • 42. The cardiovascular pharmacology of lidoflazine.
    Schaper W; Jageneau A; Xhonneux R
    Brux Med; 1970 Sep; 50(9):635-8. PubMed ID: 5510364
    [No Abstract]   [Full Text] [Related]  

  • 43. The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator.
    Schaper WK; Xhoneux R; Jageneau AH; Janssen PA
    J Pharmacol Exp Ther; 1966 May; 152(2):265-74. PubMed ID: 5944369
    [No Abstract]   [Full Text] [Related]  

  • 44. [Enhancement of the coronary dilator action of i.v. and i.c. administered adenosine following intraduodenal provision of hexobendine in dogs].
    Raberger G; Kraupp O
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):430-1. PubMed ID: 4254341
    [No Abstract]   [Full Text] [Related]  

  • 45. [Coronarodilating properties of the GABA cyclic derivative TZ-146].
    Galenko-Iaroshevskiĭ PA; Uvarov AV; Sheĭkh-Zade IuR; Cherednik IL; Popov PB; Sirotenko DV
    Biull Eksp Biol Med; 1999 Aug; 127(8):200-3. PubMed ID: 11188744
    [No Abstract]   [Full Text] [Related]  

  • 46. ITF 296, a new endothelium-independent vasodilator: comparison with nitroglycerin and isosorbide dinitrate.
    Ghaleh B; Dubois-Randé JL; Hittinger L; Berdeaux A; Giudicelli JF
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S6-12. PubMed ID: 8839220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coronary vasodilator responses to hypoxia and induced tachycardia before and after lidoflazine.
    Afonso S
    Am J Physiol; 1969 Feb; 216(2):297-300. PubMed ID: 5766980
    [No Abstract]   [Full Text] [Related]  

  • 48. Coronary hemodynamic effects of ethyl alcohol in the conscious dog.
    Pitt B; Sugishita Y; Green HL; Friesinger GC
    Am J Physiol; 1970 Jul; 219(1):175-7. PubMed ID: 4393204
    [No Abstract]   [Full Text] [Related]  

  • 49. Enhancement of coronary vasodilator action of adenosne by 1,4-Bis-(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine (Dilazep I.N.N.).
    Sano N; Katsuki S; Kawada M
    Arzneimittelforschung; 1972 Oct; 22(10):1655-8. PubMed ID: 4677053
    [No Abstract]   [Full Text] [Related]  

  • 50. [Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].
    Raff WK; Kosche F; Lochner W
    Arzneimittelforschung; 1972 Jan; 22(1):33-9. PubMed ID: 5066995
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pharmaceutical studies with diene-addition products. V. On the coronary dilator properties of a new class of amines].
    Wagner-Jauregg T; Häusler G; Demolis A
    Experientia; 1966 May; 22(5):288-9. PubMed ID: 4163248
    [No Abstract]   [Full Text] [Related]  

  • 52. [Mechanism of action of adrenaline on coronary vessels].
    Kondratovich MA
    Kardiologiia; 1969 Sep; 9(9):76-83. PubMed ID: 5367911
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of hexobendine on cardiac metabolism and blood supply.
    Raberger G; Kraupp O
    Brux Med; 1970 Sep; 50(9):645-50. PubMed ID: 5510366
    [No Abstract]   [Full Text] [Related]  

  • 54. [On the mechanism of action of coronary dilators].
    Kraupp O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):144-55. PubMed ID: 5804227
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pharmacologic bases of antiangina properties of amiodarone].
    Charlier R
    Brux Med; 1970 Sep; 50(9):651-6. PubMed ID: 5510367
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effects of flavon-7-ethyl oxyacetate on the cardiovascular system].
    Takenaka F; Takeya N; Tazume Y; Hayakawa T; Sakai M
    Kumamoto Igakkai Zasshi; 1967 Sep; 41(9):843-8. PubMed ID: 5631463
    [No Abstract]   [Full Text] [Related]  

  • 57. [On the necessity to resume and enlarge pharmacologic and clinical studies of a molecule during the advancement of its therapeutic utilization: pharmacology of trimetazidine].
    Vigne J
    Brux Med; 1970 Sep; 50(9):601-8. PubMed ID: 5510360
    [No Abstract]   [Full Text] [Related]  

  • 58. The potentiating effect of methyl hesperidin on coronary vasodilation induced by adenosine or related compounds.
    Tsunoo M; Kawazoe K; Iwata Y; Kimura F
    Arzneimittelforschung; 1967 Aug; 17(8):979-80. PubMed ID: 5632073
    [No Abstract]   [Full Text] [Related]  

  • 59. [The effect of pharmacologic agents on the blood supply of the heart in acute coronary circulatory disorders].
    Markova GA
    Vestn Akad Med Nauk SSSR; 1963; 18(1):33-5. PubMed ID: 4971962
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pharmacologic problems of the coronary circulation].
    Heidenreich O
    Hippokrates; 1966 May; 37(10):374-80. PubMed ID: 4863980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.